A posible therapeutic target for Kennedy’s disease and prostate cancer

Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei. Xavier Salvatella, IRB Barcelona.

Interaction of the androgen receptor and chaperone Hsp70 (in red) inside the cell. Blue indicates cell nuclei. Xavier Salvatella, IRB Barcelona.


The radio station COPE, the newspaper ABC, RTVE and the scientific news agency SINC, among other media, have echoed news about a study led by Xavier Salvatella, head of the Molecular Biophysics Laboratory at IRB Barcelona. This study indicates that chaperone protein Hps70 could be an attractive therapeutic target for the treatment of Kennedy’s disease, a rare neuromuscular disorder, as well as castration-resistant prostate cancer.

Link to COPE

Link to ABC 

Link to RTVE

Link to SINC 

 

Documents: